CLASSYS Inc. (KOSDAQ:214150)
43,950
-2,900 (-6.19%)
Jun 12, 2026, 3:30 PM KST
CLASSYS Revenue
CLASSYS had revenue of 87.18B KRW in the quarter ending March 31, 2026, with 13.05% growth. This brings the company's revenue in the last twelve months to 346.88B, up 28.63% year-over-year. In the year 2025, CLASSYS had annual revenue of 336.82B with 38.64% growth.
Revenue (ttm)
346.88B
Revenue Growth
+28.63%
P/S Ratio
8.27
Revenue / Employee
880.41M
Employees
394
Market Cap
2.87T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 336.82B | 93.88B | 38.64% |
| Dec 31, 2024 | 242.94B | 62.82B | 34.87% |
| Dec 31, 2023 | 180.12B | 38.32B | 27.02% |
| Dec 31, 2022 | 141.80B | 41.21B | 40.96% |
| Dec 31, 2021 | 100.60B | 24.14B | 31.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SD Biosensor | 718.78B |
| Value Added Technology | 430.30B |
| Vieworks | 243.11B |
| T&L Co., Ltd. | 157.91B |
| BioNote | 122.44B |
| Dongbang Medical | 117.37B |
| Shinhung | 104.15B |
| PCL, Inc. | 4.98B |